These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation. Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635 [TBL] [Abstract][Full Text] [Related]
3. Receptor association and tyrosine phosphorylation of S6 kinases. Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565 [TBL] [Abstract][Full Text] [Related]
4. Functional co-operation between the subunits in heterodimeric platelet-derived growth factor receptor complexes. Emaduddin M; Ekman S; Rönnstrand L; Heldin CH Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):523-8. PubMed ID: 10417313 [TBL] [Abstract][Full Text] [Related]
5. Association of coatomer proteins with the beta-receptor for platelet-derived growth factor. Hansen K; Rönnstrand L; Rorsman C; Hellman U; Heldin CH Biochem Biophys Res Commun; 1997 Jun; 235(3):455-60. PubMed ID: 9207175 [TBL] [Abstract][Full Text] [Related]
6. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation. Benito M; Lorenzo M Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110 [TBL] [Abstract][Full Text] [Related]
7. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor. Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019 [TBL] [Abstract][Full Text] [Related]
8. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation. Sachsenmaier C; Sadowski HB; Cooper JA Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880 [TBL] [Abstract][Full Text] [Related]
9. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn. Ellis C; Kasmi F; Ganju P; Walls E; Panayotou G; Reith AD Oncogene; 1996 Apr; 12(8):1727-36. PubMed ID: 8622893 [TBL] [Abstract][Full Text] [Related]
10. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling. Yamamoto M; Toya Y; Jensen RA; Ishikawa Y Exp Cell Res; 1999 Mar; 247(2):380-8. PubMed ID: 10066366 [TBL] [Abstract][Full Text] [Related]
11. Physician Education: The Erythropoietin Receptor and Signal Transduction. Yoshimura A; Arai K Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012 [TBL] [Abstract][Full Text] [Related]
12. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase. Rodrigues GA; Park M Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547 [TBL] [Abstract][Full Text] [Related]
13. A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation. Irusta PM; DiMaio D EMBO J; 1998 Dec; 17(23):6912-23. PubMed ID: 9843497 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296. Kovalenko M; Rönnstrand L; Heldin CH; Loubtchenkov M; Gazit A; Levitzki A; Böhmer FD Biochemistry; 1997 May; 36(21):6260-9. PubMed ID: 9174341 [TBL] [Abstract][Full Text] [Related]
15. Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events. Baxter RM; Secrist JP; Vaillancourt RR; Kazlauskas A J Biol Chem; 1998 Jul; 273(27):17050-5. PubMed ID: 9642269 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the platelet-derived growth factor beta-receptor kinase activity by use of synthetic peptides. Rönnstrand L; Sorokin A; Engström U; Heldin CH Biochem Biophys Res Commun; 1990 Mar; 167(3):1333-40. PubMed ID: 2157430 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of tyrosines 1158, 1162 and 1163 on a synthetic dodecapeptide by the insulin receptor protein-tyrosine kinase. Dickens M; Tavaré JM; Clack B; Ellis L; Denton RM Biochem Biophys Res Commun; 1991 Jan; 174(2):772-8. PubMed ID: 1847054 [TBL] [Abstract][Full Text] [Related]
18. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mohammadi M; Dikic I; Sorokin A; Burgess WH; Jaye M; Schlessinger J Mol Cell Biol; 1996 Mar; 16(3):977-89. PubMed ID: 8622701 [TBL] [Abstract][Full Text] [Related]
19. Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells. Bae JH; Boggon TJ; Tomé F; Mandiyan V; Lax I; Schlessinger J Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2866-71. PubMed ID: 20133753 [TBL] [Abstract][Full Text] [Related]
20. Signaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometry. Hinsby AM; Olsen JV; Bennett KL; Mann M Mol Cell Proteomics; 2003 Jan; 2(1):29-36. PubMed ID: 12601080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]